Flu Virus -Advancements in Detection & Differentiation

Influenza outbreaks and epidemics constitute ongoing risks to global human public health. Recently, human infections with A/H5N1 avian influenza viruses have intensified the potential for the emergence of an influenza A virus with pandemic potential. Laboratory identification of human influenza virus infections is commonly performed using virus isolation in cell culture, direct antigen detection, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR). In recent years commercial influenza rapid diagnostic tests have become available  which are antigen detection tests that produce results within 30 minutes. They can provide results in a clinically relevant time frame to complement the use of antiviral medications for treatment and chemoprophylaxis of influenza. 

An Emerging Infectious Disease (EID) is an infectious whose frequency has expanded in the previous 35 years and could increase in the near future. Emerging infections account for at least 12% of all human pathogens. Emerging Infectious Disease are caused by newly identified strains like SARS, AIDS that may have evolved from a known infection like influenza or spread to a new population  or strain for e.g. West Nile virus or area undergoing ecologic transformation like Lyme disease or be re-emerging infections like drug resistant tuberculosis. Of growing concern are adverse synergistic interactions between emerging diseases and other infectious and non - infectious conditions leading to the development of novel syndemics.

  • Biomarkers for influenza
  • Diseases with bioterrorism potential
  • Assays and symptoms
  • Rapid detection methods by PCR
  • Strain identification assays and rapid diagnostic testing for viral infections

Related Conference of Flu Virus -Advancements in Detection & Differentiation

August 21-23, 2017

3rd Annual Congress on Infectious Diseases

San Francisco, California, USA
September 7-9, 2017

6thEuro-Global Conference on Infectious Diseases

Paris, France
September 13-14, 2017

6th Annual Bacteriology and Parasitology Meeting

Singapore
October 30-November 1, 2017

3rd Annual Congress on Rare Diseases and Orphan Drugs


(10 Plenary Forums - 1 Event)
San Antonio, Texas, USA
November 06-07, 2017

3rd International Conference on Flu and Emerging Infectious Diseases

Las Vegas, Nevada, USA
December 07-08, 2017

EuroSciCon Conference on STD-AIDS

Rome, Italy
March 1-2, 2018

5th International congress on Infectious Diseases

Berlin, Germany
June 11-12, 2018

4th World Congress on Rare Diseases and Orphan Drugs

Dublin, Ireland
31st August-1st September 2018

International Conference on Emerging Infectious Diseases

Zurich, Switzerland

Flu Virus -Advancements in Detection & Differentiation Conference Speakers

Recommended Sessions

Related Journals

Are you interested in